Gene editing treatments in general are prohibitively expensive (At least in the US). Casgevy cures sickle cell and beta-thallasemia but I want to say it costs $300,000? For the one dose.
You’d think insurance would jump on that given how much ER visits are, and the prevalence of ER visits in that patient demographic though.
Gene editing treatments in general are prohibitively expensive (At least in the US). Casgevy cures sickle cell and beta-thallasemia but I want to say it costs $300,000? For the one dose.
You’d think insurance would jump on that given how much ER visits are, and the prevalence of ER visits in that patient demographic though.